TP53 and chronic kidney disease: The PPI results suggest that LWDH can act on CKD through multiple targets and pathways, with the top 10 targets being JUN, AKT1, TP53, RELA, MAPK1, FOS, TNF, IL6, ESR1, and RXRA.